Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02882490
Other study ID # AEPNYA 2014-2016
Secondary ID
Status Recruiting
Phase N/A
First received August 22, 2016
Last updated August 24, 2016
Start date June 2014
Est. completion date June 2017

Study information

Verified date August 2016
Source Hospital Clinic of Barcelona
Contact Blanca Garcia-Delgar, MD
Phone +34 93 227 99 74
Is FDA regulated No
Health authority Spain: Ethics Committee
Study type Interventional

Clinical Trial Summary

This is a randomized controlled trial to assess the efficacy of a parent training program to control disruptive behaviors in children with Tourette Syndrome.


Description:

Disruptive behaviors occur in 80% of children with Tourette Syndrome, and can be more disabling than the tics themselves.

The aim of this study is to assess the efficacy of a parent training program to control disruptive behaviors in children with Tourette Syndrome. In addition, social cognition will be examined in all the participants to analyze its relationship with the severity of disruptive behavior and the treatment response.

42 children with Tourette Syndrome and moderate disruptive behaviors will be randomly assigned to a 10-week Parent Training Program or a 10-week Supportive Therapy. Clinical response will be evaluated after the intervention period, and three and six months later.


Recruitment information / eligibility

Status Recruiting
Enrollment 42
Est. completion date June 2017
Est. primary completion date June 2017
Accepts healthy volunteers No
Gender Both
Age group 8 Years to 14 Years
Eligibility Inclusion Criteria:

- Fulfill DSM-5 diagnostic criteria for Tourette's Disorder

- Moderate disruptive behaviors (Home Situations Questionnaire score >3)

Exclusion Criteria:

- Lifetime history of global learning disability, autism spectrum disorder, psychosis, bipolar disorder or organic brain disorder.

- Previous parent training with qualified therapist within the last 12 months prior to assessment

- Simultaneous individual treatment for disruptive behaviors.

- Initiation or adjustment of any psychotropic medication within the last 6 weeks prior to assessment

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Intervention

Behavioral:
Parent Training

Other:
Supportive Therapy


Locations

Country Name City State
Spain Hospital Clinic Barcelona

Sponsors (2)

Lead Sponsor Collaborator
Hospital Clinic of Barcelona Spanish Association for Child and Adolescent Psychiatry (AEPNYA)

Country where clinical trial is conducted

Spain, 

References & Publications (2)

Barkley, R. A. (1999). Defiant teen: A Clinician's Manual for Assessment and Parent Training. New York: Guilford Press.

Sukhodolsky DG, Scahill L, Zhang H, Peterson BS, King RA, Lombroso PJ, Katsovich L, Findley D, Leckman JF. Disruptive behavior in children with Tourette's syndrome: association with ADHD comorbidity, tic severity, and functional impairment. J Am Acad Child Adolesc Psychiatry. 2003 Jan;42(1):98-105. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Home Situations Questionnaire (HSQ) Parent-rated scale with 16 items designed to assess behavioral non-compliance in regular home situations. Each item is rated on a 9-point Likert-type scale ranging from 1= "mild" to 9= "severe". Change from baseline to week 10; 3 months follow up; 6 months follow up No
Secondary Alabama Parenting Questionnaire 42-item clinical-administered questionnaire designed to measure the following dimensions of parenting style: 1- Positive involvement with children, 2- Supervision and monitoring, 3- Use of positive discipline technique, 4- Consistency in the use of such discipline and 5- Use of corporal punishment. Each item is scored on a 5-point, Likert-type scale from 1="never" to 5 = "always". Change from baseline to week 10; 3 months follow up; 6 months follow up No
Secondary Parent Stress Index-Short Form Parent-rated scale with 36-items questionnaire designed to measure stress in parent-child relationship. Change from baseline to week 10; 3 months follow up; 6 months follow up No
Secondary The Gilles de la Tourette Syndrome-Quality of Life Scale (GTS-QOF) Patient-reported scale with 27-items designed to measure health-related quality of life in children and adolescents with Tourette Syndrome. Change from baseline to week 10; 3 months follow up; 6 months follow up No
Secondary Yale Global Tic Severity Scale (YGTSS) Semi-structured interview to measure tic severity. After an initial inventory of current and lifetime motor and phonic tic types, current tic number, frequency, intensity, complexity and interference are rated on a 6-point scale. Maximum score is 100, resulting from three subscales: motor tic severity (maximum score 25), phonic tic severity (maximum score 25) and general impairment due to tics (maximum score 50). Change from baseline to week 10; 3 months follow up; 6 months follow up No
See also
  Status Clinical Trial Phase
Recruiting NCT04851678 - Longitudinal Impact of Stressors in Adults With Tourette Syndrome
Completed NCT02605902 - Trial to Demonstrate the Efficacy and Safety of Internet-delivered Behavioral Treatment for Adults With Tic Disorders N/A
Completed NCT04007913 - Incorporating teleCBIT Into a Hospital-Based Tic Program N/A
Completed NCT02900144 - Modified Comprehensive Behavioral Intervention for Tics (M_CBIT) N/A
Completed NCT02256475 - Safety, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome Phase 1
Completed NCT02216474 - Brain Stimulation in Movement Disorders N/A
Completed NCT01329198 - Brain Stimulation for the Treatment of Tourette Syndrome N/A
Terminated NCT00952601 - Pilot Study of the Modified Atkins Diet for Tourette Syndrome Phase 1
Enrolling by invitation NCT00355927 - Sedation During Microelectrode Recordings Before Deep Brain Stimulation for Movement Disorders. N/A
Completed NCT00206323 - A Randomized, Placebo-controlled, Tourette Syndrome Study. Phase 3
Completed NCT00004376 - Phase III Randomized, Double-Blind, Placebo-Controlled Study of Guanfacine for Tourette Syndrome and Attention Deficit Hyperactivity Disorder Phase 3
Completed NCT04498364 - Extinction Learning in Adults With Tourette Syndrome N/A
Completed NCT00755339 - Role of the Sensory Experience in Generating Motor Tics in Tourette Syndrome
Completed NCT03325010 - Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome Phase 2
Not yet recruiting NCT06081348 - Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders Phase 2
Completed NCT01719523 - Open-Trial of EPI-743 for Adults With Tourette Syndrome Phase 1
Completed NCT01702077 - Neurofeedback for Tourette Syndrome N/A
Completed NCT00231985 - Effectiveness of Behavior Therapy and Psychosocial Therapy for the Treatment of Tourette Syndrome and Chronic Tic Disorder Phase 2
Completed NCT00206336 - An Open-label Study to Determine the Efficacy and Safety of Topiramate in the Treatment of Tourette Syndrome. Phase 3
Terminated NCT03732534 - Rollover Study for Continuing NBI-98854 Administration in Pediatric Subjects With Tourette Syndrome Phase 2